Biotech22 hours ago
Biovelocità II by Sofinnova Raises 165 Million and Invests in Bioclec
Sofinnova Partners’ Biovelocità II fund raised €165 million, surpassing expectations with support from Amgen, Bristol Myers Squibb, and Pfizer. Expanding across Europe, it backs biotech startups...